genetics

genetics

genetics

The story of CRISPR in the last ten, twenty and thirty years

In January 2013, two laboratories demonstrated that CRISPR tools could be used to edit genes in human cells. Ten years later, the first patients are already benefiting from the molecular scissors to overcome incurable diseases. This week in Science, one of the pioneers of CRISPR, Nobel laureate Jennifer Doudna, summarises the history of these tools, without forgetting that it all began thirty years ago with the findings of Francis Mojica in the Santa Pola salt flats.

1

Reactions: Clinical trial tests gene therapy in severely immunodeficient children

Bubble boy syndrome is a very serious condition caused by combined immunodeficiency. It is sometimes caused by certain mutations in the gene that codes for the Artemis protein. A phase I-II clinical trial has tested a gene therapy that adds a correct copy of the gene. The results are published in the journal NEJM.

0

Reactions to the new mapping of rare disease diagnoses in Spain since 1960

A team of researchers from the Health Institute Carlos III has published an article quantifying the diagnostic delay of rare diseases in Spain with data from the period 1960-2021. The study reveals that more than half of the patients experienced a delay in diagnosis, that the average delay exceeds six years, and that both the percentage of those affected by the delay and the average time have decreased over the years.

0

Genome editing in plants: why it is urgent for Europe to change its legislation

The Spanish Confederation of Scientific Societies (COSCE) has just published a report, submitted to the EU, which proposes and compares different possibilities for reform of the regulatory framework for genome editing techniques.

1

Reaction to monkeypox genome analysis of monkeypox virus from patients in the current outbreak

A genomic analysis of monkeypox viruses from patients in the ongoing outbreak reveals that it most likely has a single origin. This 2022 monkeypox virus diverges from those of 2018-2019 in many more genetic variations than expected for Orthopoxviruses, which may represent ongoing accelerated evolution, according to the authors. The study is published in Nature Medicine.

 

Reaction to research revealing that infant microbiome development varies according to lifestyle

A metagenomic comparison of the infant gut microbiome of industrialised and non-industrialised populations reveals robust differences that researchers say are lifestyle-dependent. The research involved samples from infants of Hadza, a group of modern hunter-gatherers living in Tanzania, and is published in the journal Science.

Reactions to the finding of new combinations of mutations, 'mutational signatures', associated with specific cancers

Whole genome analysis of more than 12,000 tumors has identified new patterns of mutations associated with specific cancers. These combinations generate specific mutational signatures, the study of which provides information on environmental factors causing the mutations. The work is published in Science.

0